Recent Quarter Total Invested
$613,370
Recent Quarter Institutional Ownership Percentage
4.64%
Total Invested of Last Quarter
$727,758
Ownership Percentage of Last Quarter
4.75%
XTL Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 08/14/2024 | 198,888 | $483,000 | 0.00% | 3.65% |
| MORGAN STANLEY | 08/14/2024 | 33,151 | $80,557 | -15.37% | 0.61% |
| CITADEL ADVISORS LLC | 08/14/2024 | 15,435 | $36,581 | 13.23% | 0.28% |
| RHUMBLINE ADVISERS | 08/01/2024 | 5,584 | $13,232 | 100.00% | 0.10% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
XTL Biopharmaceuticals Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of XTLB shares?
During the previous two years, 7 institutional investors and hedge funds held shares of XTL Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
Noked Israel Ltd: 198,888
MORGAN STANLEY: 33,151
CITADEL ADVISORS LLC: 15,435
RHUMBLINE ADVISERS: 5,584
BNP PARIBAS ARBITRAGE, SNC: 0
UBS Group AG: 0
-
What percentage of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors?
4.64% of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at XTLB ?
Institutional investors have bought a total of 451,946 shares in the last 24 months. This purchase volume represents approximately $1.16 M in transactions.